Connect with us

Hi, what are you looking for?

Earnings PolicyEarnings Policy

Investing

In abortion pill arguments, Supreme Court justices seem skeptical about FDA accountability experts say

The Supreme Court on Tuesday heard arguments challenging the Food and Drug Administration’s (FDA) relaxed regulations on a widely prescribed abortion pill, and while legal experts say that the case could be tossed due to a lack of standing, the justices appeared skeptical of the idea that the FDA could face no liability. 

Erin Hawley, senior counsel for Alliance Defending Freedom, argued the case on behalf of a group of doctors challenging the FDA’s loose access restrictions on mifepristone. 

While the justices seemed skeptical that the doctors had standing to sue, they did seem to take issue with the lack of accountability for the FDA for any harms caused by the abortion pill.  

‘It’s quite troubling. It’s one thing to say no one has standing in a taxpayer case where it affects everyone. Here you have the FDA who’s not publicly accountable at all really, and has continually deregulated mifepristone. So I think that will be something the court really struggles with,’ Hawley said. 

Justice Samuel Alito at one point questioned Solicitor General Elizabeth Prelogar, arguing for the FDA. 

‘The statement was made that no court has ever previously second-guessed the FDA’s judgment about access to a drug,’ he said. ‘It’s never second-guessed that? Do you think the FDA is infallible?

‘So your argument is that it doesn’t matter if FDA flagrantly violated the law or didn’t do what it should have done, endanger the health of women,’ he said.

‘It’s just too bad, and nobody can sue in court?’ he pressed. 

Thomas Jipping, senior fellow at the Heritage Foundation, said that Alito’s questioning may have revealed his thinking on who has standing in such a matter. 

‘If you take a view of standing that results, not in these plaintiffs cannot sue, but no one can sue, maybe your view of standing is kind of misguided in the first place.,’ he said. ‘That was an interesting one.’

‘Sometimes justices ask questions, not only just for an answer on a specific legal question, but kind of they ask questions that are related to a train of thought, something that they’ve been considering,’ Jipping said. 

‘Maybe they’ve been talking about with their clerks sort of thinking out loud. And that was clearly one, that for Justice Alito and the Chief Justice. was the significant one,’ he added. 

This post appeared first on FOX NEWS

Enter Your Information Below To Receive Latest News, And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    FBI Director Christopher A. Wray, who has been increasingly under attack from congressional Republicans, pushed back against his critics in a new interview, saying...

    Economy

    Everything You Need to Know about Tax Saving Deposit Navigating the world of investments can be daunting, especially when looking for options that offer...

    Economy

    USDCHF and USDJPY: USDJPY is testing support at 150.00 The USDCHF pair jumped to 0.91126 levels on Wednesday, forming a new three-week high. The...

    Latest News

    One ripple effect of the Israel-Gaza war is the warp-speed unraveling of relations between President Biden and some of his most loyal voters: Muslims...

    Disclaimer: earningspolicy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 earningspolicy.com